By Allister Hayman2014-12-11T11:06:00
Global pharmaceutical firms are expecting to reduce the amount of real estate they own in a trend that could create a new market for property investors.
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.